ACS GCI Pharmaceutical Roundtable: Membership
The ACS GCI Pharmaceutical Roundtable invites all corporations meeting the definition of membership to consider joining. Companies are encouraged to join if they are committed to the integration of green chemistry and green engineering into the business of drug discovery and production. By joining together in the ACS GCI Pharmaceutical Roundtable, member companies benefit by catalyzing innovative approaches to improve process efficiency and product quality.
Any corporation, or subsidiary, division or unit thereof, significantly engaged in the manufacture and marketing of finished dosage form ethical pharmaceutical or biological products under his or its own brand names for the cure, alleviation, mitigation, treatment, prevention or diagnosis of disease, and significantly engaged in pharmaceutical, biopharmaceutical or biological research and development of new molecular entities or new therapies, preventative, or in vivo diagnostics, or new systems of therapy, prevention, or diagnosis and who will continue to conduct such research and development.
Associates shall be corporations, or subsidiaries, divisions or units thereof, not eligible for membership under Members above, who are:
- Significantly engaged in research and development on their own behalf or as a provider of contract research and development services to companies meeting the definition of Member, directly related to the development or production of ethical pharmaceutical or biological products for the cure, alleviation, mitigation, treatment or prevention of disease.
- Significantly engaged in the manufacture of intermediates, active pharmaceutical ingredient, or finished dosage form ethical pharmaceutical or biological products.
Associates shall have all the rights, privileges and duties prescribed by the Business Plan, and such other rights, privileges and duties as the Management Team may from time to time establish by resolution, except the right to vote.
The Roundtable is unique among organizations supported by the industry.
The mission, strategic priorities, and services provided by the organization can only be attained through the collaboration of the Green Chemistry Institute providing technical focus and a network of international green chemistry associations with the member companies identifying technical challenges and providing the pharmaceutical company perspective and expertise.
Strength through Collaboration
The strength of the Roundtable is more influential than the sum of its parts.
This collaboration results in a strong organization to prioritize research needs and influence research agendas, to interact with federal and international agencies and organizations, and to improve cost effectiveness of investment in the design and implementation of green chemistry and engineering tools specific to the industry.
The partnership also benefits from a global network of 25 international ACS Green Chemistry Institute® (ACS GCI) affiliates, an extensive network of academic researchers across the world, and an affiliation with the American Chemical Society (ACS).